Search results
Found 41211 matches for
Today, the University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%. The new study published in the Lancet is the first peer-reviewed publication of phase 3 data from studies of a vaccine against the coronavirus.
MSc in Health Service Improvement and Evaluation
MSc in Health Service Improvement and Evaluation offered by the Nuffield Department of Medicine, University of Oxford
François Nosten: Between research and humanitarian
Combining healthcare and research allow Professor Nosten to implement a new treatment regimen as soon as the results from clinical trials are available, which is beneficial to patients and highly rewarding for researchers.